Glaukos Corp (GKOS) - Product Pipeline Analysis, 2018 Update

Scope

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Glaukos Corp Company Overview 6

Glaukos Corp Company Snapshot 6

Glaukos Corp Pipeline Products and Ongoing Clinical Trials Overview 6

Glaukos Corp - Pipeline Analysis Overview 8

Glaukos Corp - Key Facts 8

Glaukos Corp - Major Products and Services 9

Glaukos Corp Pipeline Products by Development Stage 10

Glaukos Corp Ongoing Clinical Trials by Trial Status 12

Glaukos Corp Pipeline Products Overview 15

GTS400 15

GTS400 Product Overview 15

iDose Travoprost Intraocular Implant 16

iDose Travoprost Intraocular Implant Product Overview 16

iDose Travoprost Intraocular Implant Clinical Trial 17

IOP Sensor System 18

IOP Sensor System Product Overview 18

iStent Infinite 19

iStent Infinite Product Overview 19

iStent Infinite Clinical Trial 20

iStent inject Trabecular Micro-Bypass Stent 21

iStent inject Trabecular Micro-Bypass Stent Product Overview 21

iStent inject Trabecular Micro-Bypass Stent Clinical Trial 22

iStent SA 25

iStent SA Product Overview 25

iStent SA Clinical Trial 26

iStent Supra Suprachoroidal Micro-Bypass Stent 30

iStent Supra Suprachoroidal Micro-Bypass Stent Product Overview 30

iStent Supra Suprachoroidal Micro-Bypass Stent Clinical Trial 31

Glaukos Corp - Key Competitors 34

Glaukos Corp - Key Employees 35

Glaukos Corp - Locations And Subsidiaries 36

Head Office 36

Other Locations & Subsidiaries 36

Recent Developments 37

Glaukos Corp, Recent Developments 37

Jun 25, 2018: Glaukos' iStent inject micro-bypass device gets FDA approval 37

May 09, 2018: Glaukos Announces First Quarter 2018 Financial Results 37

Apr 14, 2018: IDE Pivotal Trial Results for Glaukos iStent inject Show Significant Reductions in Unmedicated IOP in Glaucoma Subjects Undergoing Cataract Surgery 38

Apr 11, 2018: Multiple Surgeon Presentations to Include Glaukos Technologies at 2018 American Society of Cataract and Refractive Surgery 39

Feb 28, 2018: Glaukos Reports Fourth Quarter and Full Year 2017 Financial Results 41

Feb 28, 2018: Raysearch Laboratories: First clinic now live with RayCare 42

Feb 27, 2018: Glaukos Technologies Featured in Numerous Presentations at 2018 American Glaucoma Society Meeting 43

Feb 27, 2018: International Study Shows Long-Term Titrated IOP Control with 1, 2 or 3 Glaukos iStent Trabecular Micro-Bypass Stents in Open-Angle Glaucoma Patients 44

Feb 26, 2018: Apollo Endosurgery Announces First ORBERA U.S. Post-Approval Publication 45

Feb 08, 2018: Glaukos iStent Trabecular Micro-Bypass Stent Reduced IOP and Lowered Medication Burden in Patients with Severe Glaucoma, According to New Study 46

Appendix 48

Methodology 48

About GlobalData 51

Contact Us 51

Disclaimer 51

List Of Figure

List of Figures

Glaukos Corp Pipeline Products by Equipment Type 7

Glaukos Corp Pipeline Products by Development Stage 10

Glaukos Corp Ongoing Clinical Trials by Trial Status 12

List Of Table

List of Tables

Glaukos Corp Pipeline Products and Ongoing Clinical Trials Overview 6

Glaukos Corp Pipeline Products by Equipment Type 7

Glaukos Corp Pipeline Products by Indication 7

Glaukos Corp Ongoing Clinical Trials by Trial Status 7

Glaukos Corp, Key Facts 8

Glaukos Corp, Major Products and Services 9

Glaukos Corp Number of Pipeline Products by Development Stage 10

Glaukos Corp Pipeline Products Summary by Development Stage 11

Glaukos Corp Ongoing Clinical Trials by Trial Status 12

Glaukos Corp Ongoing Clinical Trials Summary 13

GTS400 - Product Status 15

GTS400 - Product Description 15

iDose Travoprost Intraocular Implant - Product Status 16

iDose Travoprost Intraocular Implant - Product Description 16

iDose Travoprost Intraocular Implant - A Prospective, Randomized, Phase III IND Study of iDose Travoprost in Open-angle Glaucoma Patients 17

iDose Travoprost Intraocular Implant - Assessment of iDose Delivery System's Safety and Preliminary Efficacy for the Reduction of Elevated Intraocular Pressure 17

IOP Sensor System - Product Status 18

IOP Sensor System - Product Description 18

iStent Infinite - Product Status 19

iStent Infinite - Product Description 19

iStent Infinite - A Prospective, Multi-center, Single-arm Clinical Study to Evaluate the Safety and Efficacy of iStent Infinite in Refractory Glaucoma Patients 20

iStent inject Trabecular Micro-Bypass Stent - Product Status 21

iStent inject Trabecular Micro-Bypass Stent - Product Description 21

iStent inject Trabecular Micro-Bypass Stent - A Prospective Evaluation of Mild to Moderate Open-angle Glaucoma Subjects Treated with Two Second Generation Micro-bypass Stents and One Suprachoroidal Stent 22

iStent inject Trabecular Micro-Bypass Stent - A Prospective Evaluation of Mild to Moderate Open-angle Glaucoma Subjects with Cataract Treated with Cataract Surgery Plus One Trabecular Micro-bypass Stent and One Suprachoroidal Stent 22

iStent inject Trabecular Micro-Bypass Stent - A Prospective Evaluation of the Second Generation iStent Inject in Open-angle Glaucoma Subjects on Two Preoperative Topical Ocular Hypotensive Medications 23

iStent inject Trabecular Micro-Bypass Stent - A Prospective, Randomized Evaluation of Subjects with Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naive to Medical and Surgical Therapy, Treated with Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost Ophthalmic Solution 0.004% 23

iStent inject Trabecular Micro-Bypass Stent - A Prospective, Randomized, Single-masked, Controlled, Parallel Groups, Multicenter Clinical Investigation of the Glaukos Trabecular Micro-bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction with Cataract Surgery 24

iStent inject Trabecular Micro-Bypass Stent - A Randomized Controlled Trial of Cataract Surgery Versus Combined Cataract Surgery with Insertion of iStent Inject 24

iStent SA - Product Status 25

iStent SA - Product Description 25

iStent SA - A Prospective Evaluation of Mild to Moderate Open-angle Glaucoma Subjects Treated with Second Generationtrabecular Micro-bypass Stents and One Suprachoroidal Stent a Multicenter Study According to Mpg §23.B 26

iStent SA - A Prospective Evaluation of Open-angle Glaucoma Subjects on One Topical Hypotensive Medication (Prostaglandin) Treated with Two Trabecular Micro-bypass Stents (iStent Inject) 26

iStent SA - A Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medications (One a Prostaglandin) Treated with Two Trabecular Micro-bypass Stents (iStent Inject) and a Postoperative Topical Prostaglandin 27

iStent SA - Initial Phase of U.S. IDE Clinical Trial for Standalone Version of iStent inject 27

iStent SA - The Effect of Glaucoma Surgery on Aqueous Dynamics in Patients with Glaucoma or Ocular Hypertension: An Observational Study 28

iStent SA - Trabeculectomy with MMC and I Stent in Uveitic Glaucoma and POAG : Outcomes and Prognostic Factors 28

iStent SA - US Investigational Device Exemption (IDE) Pivotal Study of iStent SA Standalone Micro-Invasive Glaucoma Surgery 29

iStent Supra Suprachoroidal Micro-Bypass Stent - Product Status 30

iStent Supra Suprachoroidal Micro-Bypass Stent - Product Description 30

iStent Supra Suprachoroidal Micro-Bypass Stent - A Prospective Evaluation of Mild to Moderate Open-angle Glaucoma Subjects Treated with Second Generationtrabecular Micro-bypass Stents and One Suprachoroidal Stent a Multicenter Study According to Mpg §23.B 31

iStent Supra Suprachoroidal Micro-Bypass Stent - A Prospective Evaluation of Mild to Moderate Open-angle Glaucoma Subjects Treated with Two Second Generation Micro-bypass Stents and One Suprachoroidal Stent 31

iStent Supra Suprachoroidal Micro-Bypass Stent - A Prospective Evaluation of Mild to Moderate Open-angle Glaucoma Subjects with Cataract Treated with Cataract Surgery Plus One Trabecular Micro-bypass Stent and One Suprachoroidal Stent 32

iStent Supra Suprachoroidal Micro-Bypass Stent - A Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medication Treated With One Suprachoroidal Stent 32

iStent Supra Suprachoroidal Micro-Bypass Stent - A Prospective Evaluation of Open-angle Glaucoma Subjects with One Prior Trabeculectomy Treated Concurrently with One Suprachoroidal Stent and Two Trabecular Micro-bypass Stents and a Postoperative Prostaglandin 33

iStent Supra Suprachoroidal Micro-Bypass Stent - A Prospective, Randomized, Single-masked, Controlled, Parallel Groups, Multicenter Clinical Investigation of the Glaukos Suprachoroidal Stent Model G3 in Conjunction with Cataract Surgery 33

Glaukos Corp, Key Employees 35

Glaukos Corp, Subsidiaries 36

Glossary 50

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Products

Companies